| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 652851 | 67311 | CINFATOS ANTITUSIVO INFANTIL 1 mg / ml SOLUCION ORAL | CINFATOS ANTITUSIVO INFANTIL 1 mg / ml SOLUCION ORAL, 1 frasco de 125 ml | 1 mg/ml | 6 | 125 | 26 | 1 frasco de 125 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67311/67311_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67311/67311_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2005-12-01 | 1 | 1 | 1 | 2005-12-01 | 2005-12-01 | 1 | 2016-09-30 | View Edit Delete | ||||||||||||
| 663100 | 70997 | LAITOS 3 mg/ml JARABE | LAITOS 3 mg/ml JARABE, 1 frasco de 200 ml | 3 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70997/70997_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70997/70997_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1614 | 1614 | 2009-06-03 | 1 | 1 | 1 | 2009-06-04 | 2009-06-03 | 1 | 2011-05-27 | View Edit Delete | ||||||||||||
| 678649 | 63626 | AMBROXOL CINFA 3 MG/ML JARABE EFG | AMBROXOL CINFA 3 MG/ML JARABE EFG, 1 frasco de 200 ml | 3 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63626/63626_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63626/63626_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2001-01-26 | 1 | 1 | 1 | 2001-01-26 | 2001-01-26 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 682385 | 60898 | CINFATOS EXPECTORANTE 2 mg/ml + 20 mg/ml SOLUCION ORAL | CINFATOS EXPECTORANTE 2 mg/ml + 20 mg/ml SOLUCION ORAL , 1 frasco de 125 ml | 2 mg/ml + 20 mg/ml | 6 | 125 | 26 | 1 frasco de 125 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60898/60898_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60898/60898_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 1995-10-01 | 1 | 1 | 1 | 1995-10-01 | 1995-10-01 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 688046 | 75517 | RESPIBIEN FRESHMINT 0,5 mg/ ml SOLUCION PARA PULVERIZACION NASAL | RESPIBIEN FRESHMINT 0,5 mg/ ml SOLUCION PARA PULVERIZACION NASAL, 1 envase pulverizador de 15 ml | 0,5 mg/ml | 39 | 15 | 26 | 1 envase pulverizador de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75517/75517_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75517/75517_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2012-02-22 | 1 | 1 | 1 | 2012-02-22 | 2012-02-22 | 1 | 2012-08-20 | View Edit Delete | ||||||||||||
| 698158 | 77553 | MEMANTINA KERN PHARMA 10 MG/ML SOLUCION ORAL EFG | MEMANTINA KERN PHARMA 10 MG/ML SOLUCION ORAL EFG , 1 frasco de 100 ml | 10 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77553/77553_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77553/77553_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2013-05-28 | 1 | 1 | 1 | 2013-05-28 | 2013-05-28 | 1 | 2013-07-24 | View Edit Delete | ||||||||||||
| 700458 | 78243 | TEGLUTIK 5MG/ML SUSPENSION ORAL | TEGLUTIK 5MG/ML SUSPENSION ORAL, 1 frasco de 300 ml | 5 mg/ml | 6 | 300 | 26 | 1 frasco de 300 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78243/78243_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78243/78243_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1473 | 1473 | 2014-02-07 | 1 | 1 | 1 | 2014-02-07 | 2014-02-12 | 1 | 2014-06-27 | View Edit Delete | ||||||||||||
| 700977 | 78316 | MEMANTINA CINFA 5 MG/PULSACION SOLUCION ORAL EFG | MEMANTINA CINFA 5 MG/PULSACION SOLUCION ORAL EFG , 100 ml de solución | 5 mg/dosis | 6 | 200 | 13 | 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78316/78316_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78316/78316_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 684 | 684 | 2013-12-16 | 1 | 1 | 1 | 2013-12-16 | 2013-12-16 | 1 | 2014-06-14 | View Edit Delete | ||||||||||||
| 701783 | 78557 | MEMANTINA AUROVITAS SPAIN 5 MG/PULSACION SOLUCION ORAL EFG | MEMANTINA AUROVITAS SPAIN 5 MG/PULSACION SOLUCION ORAL EFG , Frasco de 100 ml | 5 mg/dosis | 6 | 200 | 13 | 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78557/78557_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78557/78557_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2014-03-12 | 1 | 1 | 1 | 2014-03-12 | 2014-03-12 | 1 | 2014-06-27 | View Edit Delete | ||||||||||||
| 703377 | 78985 | CINFATOS EXPECTORANTE 10 mg + 100 mg solución oral en sobres | CINFATOS EXPECTORANTE 10 mg + 100 mg solución oral en sobres, 18 sobres | 10 mg + 100 mg | 35 | 18 | 64 | 18 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78985/78985_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78985/78985_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2014-08-18 | 1 | 1 | 1 | 2014-08-18 | 2014-08-18 | 1 | 2015-09-15 | View Edit Delete | ||||||||||||
| 709221 | 80484 | CITICOLINA CINFAMED 1000 MG SOLUCION ORAL EFG | CITICOLINA CINFAMED 1000 MG SOLUCION ORAL EFG, 10 sobres de 10 ml | 1.000 mg | 35 | 10 | 64 | 10 sobres de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80484/80484_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80484/80484_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2015-12-15 | 1 | 1 | 1 | 2021-01-12 | 2021-01-12 | 1 | 2021-04-12 | View Edit Delete | ||||||||||||
| 713502 | 81388 | DESLORATADINA VIR 0,5 MG/ML SOLUCION ORAL EFG | DESLORATADINA VIR 0,5 MG/ML SOLUCION ORAL EFG, 1 Frasco de 120 ml | 0,5 mg/ml | 6 | 120 | 26 | 1 Frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81388/81388_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81388/81388_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | 3050 | 2016-11-08 | 1 | 1 | 1 | 2016-11-11 | 2016-11-08 | 1 | 2026-03-27 | View Edit Delete | ||||||||||||
| 715598 | 81946 | DOLOSTOP 500 MG SOLUCION ORAL | DOLOSTOP 500 MG SOLUCION ORAL, 10 sobres | 500 mg | 35 | 10 | 64 | 10 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81946/81946_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81946/81946_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2017-04-10 | 1 | 1 | 1 | 2017-04-11 | 2017-04-10 | 1 | 2017-10-09 | View Edit Delete | ||||||||||||
| 715600 | 81947 | DOLOSTOP 650 MG SOLUCION ORAL | DOLOSTOP 650 MG SOLUCION ORAL, 10 sobres | 650 mg | 35 | 10 | 64 | 10 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81947/81947_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81947/81947_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2017-04-10 | 1 | 1 | 1 | 2017-04-11 | 2017-04-10 | 1 | 2017-10-09 | View Edit Delete | ||||||||||||
| 715602 | 81948 | DOLOSTOP 1 G SOLUCION ORAL | DOLOSTOP 1 G SOLUCION ORAL, 10 sobres | 1.000 mg | 35 | 10 | 64 | 10 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81948/81948_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81948/81948_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2017-04-10 | 1 | 1 | 1 | 2017-04-11 | 2017-04-10 | 1 | 2017-10-09 | View Edit Delete | ||||||||||||
| 718654 | 57623 | CINFATOS ANTITUSIVO 2 mg/ ml SOLUCION ORAL | CINFATOS ANTITUSIVO 2 mg/ ml SOLUCION ORAL, 1 frasco de 125 ml (PET) | 2 mg/ml | 6 | 125 | 26 | 1 frasco de 125 ml (PET) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57623/57623_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57623/57623_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 1988-07-01 | 1 | 1 | 1 | 1988-07-01 | 2017-08-02 | 1 | 2022-07-26 | View Edit Delete | ||||||||||||
| 718655 | 57623 | CINFATOS ANTITUSIVO 2 mg/ ml SOLUCION ORAL | CINFATOS ANTITUSIVO 2 mg/ ml SOLUCION ORAL, 1 frasco de 200 ml (PET) | 2 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml (PET) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57623/57623_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57623/57623_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 1988-07-01 | 1 | 1 | 1 | 1988-07-01 | 2017-08-02 | 1 | 2018-10-30 | View Edit Delete | ||||||||||||
| 718787 | 82374 | TUSCLIN JARABE | TUSCLIN JARABE, 1 Frasco de 100 ml | 7 mg/ml | 6 | 100 | 26 | 1 Frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82374/82374_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82374/82374_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | 945 | 2017-09-01 | 1 | 1 | 1 | 2017-09-02 | 2017-09-01 | 1 | 2017-10-27 | View Edit Delete | ||||||||||||
| 719052 | 60898 | CINFATOS EXPECTORANTE 2 mg/ml + 20 mg/ml SOLUCION ORAL | CINFATOS EXPECTORANTE 2 mg/ml + 20 mg/ml SOLUCION ORAL, 1 frasco de 125 ml | 2 mg/ml + 20 mg/ml | 6 | 125 | 26 | 1 frasco de 125 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60898/60898_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60898/60898_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 1995-10-01 | 1 | 1 | 1 | 1995-10-01 | 2017-09-20 | 1 | 2018-10-30 | View Edit Delete | ||||||||||||
| 719053 | 60898 | CINFATOS EXPECTORANTE 2 mg/ml + 20 mg/ml SOLUCION ORAL | CINFATOS EXPECTORANTE 2 mg/ml + 20 mg/ml SOLUCION ORAL, 1 frasco de 200 ml | 2 mg/ml + 20 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60898/60898_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60898/60898_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 1995-10-01 | 1 | 1 | 1 | 1995-10-01 | 2017-09-20 | 1 | 2018-10-30 | View Edit Delete | ||||||||||||
| 720018 | 63626 | AMBROXOL CINFA 3 MG/ML JARABE EFG | AMBROXOL CINFA 3 MG/ML JARABE EFG, Frasco de 200 ml (PET) | 3 mg/ml | 6 | 200 | 26 | Frasco de 200 ml (PET) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63626/63626_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63626/63626_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2001-01-26 | 1 | 1 | 1 | 2001-01-26 | 2017-12-04 | 1 | 2018-10-30 | View Edit Delete | ||||||||||||
| 721190 | 81847 | CINFAHELIX JARABE | CINFAHELIX JARABE,1 Frasco de 200 ml | 8,25 mg/ml | 6 | 200 | 26 | 1 Frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81847/81847_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81847/81847_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2017-03-06 | 1 | 1 | 1 | 2017-03-07 | 2018-03-23 | 1 | 2018-10-30 | View Edit Delete | ||||||||||||
| 725173 | 72689 | CINFATOS DESCONGESTIVO SOLUCION ORAL | CINFATOS DESCONGESTIVO SOLUCION ORAL, 1 frasco de 125 ml (PET) | 2 mg/ml + 6 mg/ml + 0,25 mg/ml | 6 | 125 | 26 | 1 frasco de 125 ml (PET) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72689/72689_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72689/72689_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2010-09-02 | 1 | 1 | 1 | 2019-08-01 | 2019-08-01 | 1 | 2024-06-13 | View Edit Delete | ||||||||||||
| 725174 | 72689 | CINFATOS DESCONGESTIVO SOLUCION ORAL | CINFATOS DESCONGESTIVO SOLUCION ORAL, 1 frasco de 200 ml (PET) | 2 mg/ml + 6 mg/ml + 0,25 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml (PET) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72689/72689_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72689/72689_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2010-09-02 | 1 | 1 | 1 | 2019-08-01 | 2019-08-01 | 1 | 2024-06-13 | View Edit Delete | ||||||||||||
| 725444 | 84057 | ALITRETINOINA IFC 10 MG CAPSULAS BLANDAS EFG | ALITRETINOINA IFC 10 MG CAPSULAS BLANDAS EFG, 30 cápsulas | 10 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84057/84057_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84057/84057_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1371 | 1371 | 2019-04-24 | 1 | 1 | 1 | 2019-04-25 | 2019-04-24 | 1 | 2019-10-21 | View Edit Delete | ||||||||||||
| 725445 | 84058 | ALITRETINOINA IFC 30 MG CAPSULAS BLANDAS EFG | ALITRETINOINA IFC 30 MG CAPSULAS BLANDAS EFG, 30 cápsulas | 30 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84058/84058_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84058/84058_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1371 | 1371 | 2019-04-24 | 1 | 1 | 1 | 2019-04-25 | 2019-04-24 | 1 | 2019-10-21 | View Edit Delete | ||||||||||||
| 725865 | 84165 | AMBROXOL STADA 6 MG/ML JARABE EFG | AMBROXOL STADA 6 MG/ML JARABE EFG 1 frasco de 250 ml | 6 mg/ml | 6 | 250 | 26 | 1 frasco de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84165/84165_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84165/84165_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2019-05-24 | 1 | 1 | 1 | 2019-05-25 | 2019-05-24 | 1 | 2019-12-05 | View Edit Delete | ||||||||||||
| 727648 | 84747 | PEZIMAX 2 MG/ML SOLUCION ORAL | PEZIMAX 2 MG/ML SOLUCION ORAL, 1 frasco de 150 ml | 2 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84747/84747_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84747/84747_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 30261 | 30261 | 2019-12-26 | 1 | 1 | 1 | 2019-12-27 | 2019-12-26 | 1 | 2020-12-15 | View Edit Delete | ||||||||||||
| 728062 | 84901 | GASTROPAN 90 MG/50 MG CAPSULAS BLANDAS GASTRORRESISTENTES | GASTROPAN 90 MG/50 MG CAPSULAS BLANDAS GASTRORRESISTENTES 14 cápsulas | 90 mg/50 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84901/84901_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84901/84901_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 867 | 30090 | 2020-02-25 | 1 | 1 | 1 | 2020-02-26 | 2020-02-25 | 1 | 2022-11-08 | View Edit Delete | ||||||||||||
| 728063 | 84901 | GASTROPAN 90 MG/50 MG CAPSULAS BLANDAS GASTRORRESISTENTES | GASTROPAN 90 MG/50 MG CAPSULAS BLANDAS GASTRORRESISTENTES 42 cápsulas | 90 mg/50 mg | 5 | 42 | 43 | 42 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84901/84901_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84901/84901_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 867 | 30090 | 2020-02-25 | 1 | 1 | 1 | 2020-02-26 | 2020-02-25 | 1 | 2023-09-01 | View Edit Delete | ||||||||||||
| 728064 | 84901 | GASTROPAN 90 MG/50 MG CAPSULAS BLANDAS GASTRORRESISTENTES | GASTROPAN 90 MG/50 MG CAPSULAS BLANDAS GASTRORRESISTENTES 84 cápsulas | 90 mg/50 mg | 5 | 84 | 43 | 84 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84901/84901_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84901/84901_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 867 | 30090 | 2020-02-25 | 1 | 1 | 1 | 2020-02-26 | 2020-02-25 | 1 | 2025-10-03 | View Edit Delete | ||||||||||||
| 729674 | 80484 | CITICOLINA CINFAMED 1000 MG SOLUCION ORAL EFG | CITICOLINA CINFAMED 1000 MG SOLUCION ORAL EFG, 30 (3 x 10) sobres de 10 ml | 1.000 mg | 35 | 30 | 64 | 30 (3 x 10) sobres de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80484/80484_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80484/80484_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2015-12-15 | 1 | 1 | 1 | 2021-01-12 | 2021-01-12 | 1 | 2021-02-12 | View Edit Delete | ||||||||||||
| 730036 | 85664 | CINFATOS NOCHE 1,33 MG/ML + 2 MG/ML SOLUCION ORAL | CINFATOS NOCHE 1,33 MG/ML + 2 MG/ML SOLUCION ORAL, 1 frasco de 150 ml (Frasco PET) | 1,33 mg/ml + 2 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml (Frasco PET) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85664/85664_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85664/85664_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2020-12-22 | 1 | 1 | 1 | 2021-12-23 | 2021-12-23 | 1 | 2021-12-24 | View Edit Delete | ||||||||||||
| 731254 | 1201524001 | VAZKEPA 998 MG CAPSULAS BLANDAS | VAZKEPA 998 MG CAPSULAS BLANDAS 120 cápsulas | 998 mg | 6 | 120 | 43 | 120 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201524001/1201524001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201524001/1201524001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2359 | 15657 | 2021-07-29 | 1 | 1 | 1 | 2021-07-30 | 2021-07-29 | 1 | 2023-06-09 | View Edit Delete | ||||||||||||
| 733070 | 86655 | CITICOLINA KERN PHARMA 1.000 MG SOLUCIÓN ORAL EFG | CITICOLINA KERN PHARMA 1.000 MG SOLUCIÓN ORAL EFG, 10 sobres de 10 ml | 1.000 mg | 35 | 10 | 64 | 10 sobres de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86655/86655_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86655/86655_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2022-03-21 | 1 | 1 | 1 | 2022-03-22 | 2022-03-21 | 1 | 2023-03-13 | View Edit Delete | ||||||||||||
| 733071 | 86655 | CITICOLINA KERN PHARMA 1.000 MG SOLUCIÓN ORAL EFG | CITICOLINA KERN PHARMA 1.000 MG SOLUCIÓN ORAL EFG, 30 (3 x 10 sobres) sobres de 10 ml | 1.000 mg | 35 | 30 | 64 | 30 (3 x 10 sobres) sobres de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86655/86655_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86655/86655_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2022-03-21 | 1 | 1 | 1 | 2022-03-22 | 2022-03-21 | 1 | 2023-03-13 | View Edit Delete | ||||||||||||
| 733072 | 86656 | CITICOLINA NORMOGEN 1000 MG SOLUCIÓN ORAL EFG | CITICOLINA NORMOGEN 1000 MG SOLUCIÓN ORAL EFG, 10 sobres de 10 ml | 1.000 mg | 35 | 10 | 64 | 10 sobres de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86656/86656_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86656/86656_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-03-21 | 1 | 1 | 1 | 2022-03-22 | 2022-03-21 | 1 | 2023-03-13 | View Edit Delete | ||||||||||||
| 733073 | 86656 | CITICOLINA NORMOGEN 1000 MG SOLUCIÓN ORAL EFG | CITICOLINA NORMOGEN 1000 MG SOLUCIÓN ORAL EFG, 30 (3 x 10) sobres de 10 ml | 1.000 mg | 35 | 30 | 64 | 30 (3 x 10) sobres de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86656/86656_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86656/86656_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-03-21 | 1 | 1 | 1 | 2022-03-22 | 2022-03-21 | 1 | 2023-03-13 | View Edit Delete | ||||||||||||
| 744934 | 87322 | LAPRYSTA 10 MG/ML JARABE EFG | LAPRYSTA 10 MG/ML JARABE EFG, 200 ml | 10 mg/ml | 6 | 200 | 26 | 200 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87322/87322_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87322/87322_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | 30261 | 2022-05-19 | 1 | 1 | 1 | 2022-05-20 | 2022-05-19 | 1 | 2022-12-15 | View Edit Delete | ||||||||||||
| 748343 | 60898 | CINFATOS EXPECTORANTE 2 mg/ml + 20 mg/ml SOLUCION ORAL | CINFATOS EXPECTORANTE 2 mg/ml + 20 mg/ml SOLUCION ORAL , 1 frasco de 200 ml | 2 mg/ml + 20 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60898/60898_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60898/60898_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 1995-10-01 | 1 | 1 | 1 | 1995-10-01 | 2003-02-12 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 756029 | 87837 | IBUPROFENO RAPID STADAPHARM 400 MG CAPSULAS BLANDAS | IBUPROFENO RAPID STADAPHARM 400 MG CAPSULAS BLANDAS, 20 cápsulas | 400 mg | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87837/87837_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87837/87837_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2022-06-16 | 1 | 1 | 1 | 2022-06-17 | 2022-06-16 | 1 | 2023-08-02 | View Edit Delete | ||||||||||||
| 757807 | 02219006 | EBIXA 5 mg/pulsacion SOLUCION ORAL | EBIXA 5 mg/pulsacion SOLUCION ORAL , 1 frasco de 100 ml (200 dosis) | 5 mg/dosis | 6 | 200 | 13 | 1 frasco de 100 ml (200 dosis) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02219006/02219006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02219006/02219006_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1250 | 1710 | 2002-06-21 | 1 | 1 | 1 | 2002-06-21 | 2002-06-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 763735 | 89150 | TOSHEDRA 7 MG/ML JARABE | TOSHEDRA 7 MG/ML JARABE, 150 ml | 7 mg/ml | 6 | 150 | 26 | 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89150/89150_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89150/89150_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2023-11-13 | 1 | 1 | 1 | 2023-11-14 | 2023-11-13 | 1 | 2024-07-12 | View Edit Delete | ||||||||||||
| 763737 | 89151 | TOSHEDRA 35 MG JARABE EN SOBRES | TOSHEDRA 35 MG JARABE EN SOBRES, 20 sobres de 5 ml | 35 mg | 35 | 20 | 64 | 20 sobres de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89151/89151_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89151/89151_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2023-11-13 | 1 | 1 | 1 | 2023-11-14 | 2023-11-13 | 1 | 2024-07-12 | View Edit Delete | ||||||||||||
| 764321 | 89352 | REVISEA 80 MG CÁPSULAS BLANDAS | REVISEA 80 MG CÁPSULAS BLANDAS, 30 cápsulas | 80 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89352/89352_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89352/89352_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1534 | 1534 | 2024-02-15 | 1 | 1 | 1 | 2024-02-16 | 2024-02-15 | 1 | 2024-08-12 | View Edit Delete | ||||||||||||
| 765895 | 89725 | HIDROFEROL SEMANAL 100 MICROGRAMOS CAPSULAS BLANDAS | HIDROFEROL SEMANAL 100 MICROGRAMOS CAPSULAS BLANDAS, 4 cápsulas | 100 microgramos | 5 | 4 | 43 | 4 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89725/89725_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89725/89725_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41329 | 41329 | 2024-10-03 | 1 | 1 | 1 | 2024-10-03 | 2024-10-03 | 1 | 2025-07-29 | View Edit Delete | ||||||||||||
| 767867 | 90369 | KETYALIX 25 MG/ML SUSPENSION ORAL | KETYALIX 25 MG/ML SUSPENSION ORAL, 1 frasco de 50 ml | 25 mg/ml | 6 | 50 | 26 | 1 frasco de 50 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90369/90369_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90369/90369_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1473 | 1473 | 2025-06-10 | 1 | 1 | 1 | 2025-06-10 | 2025-06-10 | 1 | 2025-09-11 | View Edit Delete | ||||||||||||
| 768202 | 82182 | FLECTORMED 180 MG APOSITO ADHESIVO MEDICAMENTOSO | FLECTORMED 180 MG APOSITO ADHESIVO MEDICAMENTOSO, 5 apósitos | 180 mg | 35 | 5 | 69 | 5 apósitos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82182/82182_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82182/82182_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11580 | 44585 | 2018-03-23 | 1 | 1 | 1 | 2018-03-23 | 2025-07-30 | 1 | 2026-04-08 | View Edit Delete | ||||||||||||
| 769517 | 90369 | KETYALIX 25 MG/ML SUSPENSION ORAL | KETYALIX 25 MG/ML SUSPENSION ORAL, 2 frascos de 50 ml | 25 mg/ml | 6 | 100 | 26 | 2 frascos de 50 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90369/90369_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90369/90369_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1473 | 1473 | 2025-06-10 | 1 | 1 | 1 | 2025-06-10 | 2025-12-15 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 816728 | 51889 | RESPIBIEN 0,5 mg/ml solución para pulverización nasal | RESPIBIEN 0,5 mg/ml solución para pulverización nasal , 1 envase pulverizador de 15 ml | 0,5 mg/ml | 6 | 15 | 26 | 1 envase pulverizador de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/51889/51889_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/51889/51889_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 1973-12-01 | 1 | 1 | 1 | 1973-12-01 | 1973-12-01 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 925933 | 02218006 | AXURA 5 mg/PULSACION, SOLUCION ORAL | AXURA 5 mg/PULSACION, SOLUCION ORAL, 1 frasco de 100 ml (200 dosis) | 5 mg/dosis | 6 | 200 | 13 | 1 frasco de 100 ml (200 dosis) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02218006/02218006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02218006/02218006_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1839 | 42041 | 2004-04-19 | 1 | 1 | 1 | 2004-04-19 | 2004-04-19 | 1 | 2012-01-09 | View Edit Delete |